York Nordic is pleased to announce the introduction of the new Motivator walking poles with a newly designed ergonomic grip that lends support to Nordic Walking to ensure maximum benefit and comfort to the user.
Read Press ReleaseThe research opens the doors for promising applications that can help people with neurological diseases such as Parkinson's.
Read Press ReleaseLocal Discovery Senior Living communities are helping residents overcome the negative effects of isolation and physical limitations through at-home exercise and Parkinson's aqua therapy sessions.
Read Press ReleaseThe Toothbrush Pillow idea originally to the inventors after watching their daughter struggle with keeping the sink clean and her toothbrush clean during the process of brushing her teeth. After over two years since the originally idea, we have discovered that millions of people may find our product helpful for their normal twice a day habit, brushing teeth!
Read Press ReleaseA Mom of an autistic child has teamed up with renown pediatric neurologist to create a product for Autism. After her son refused to take the 40 capsules, she developed MitoSpectra. MitoSpectra is now being sold globally. MitoSpectra LLC seeks to expand its reach around the world.
Read Press ReleaseWorld Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise.
The Blechman Foundation for Parkinson's Research will hold its first New York City fundraiser on Wednesday, April 30, 2014, at STK Meatpacking, 26 Little West 12th St., from 6:30 p.m. to 8:30 p.m.
Read Press ReleaseThe U-Step Walker Rollator is a new product made for people with gait, ambulation and balance difficulties. Parkinson's Disease, Multiple Sclerosis and Stroke can limit a person's ability to safely walk. The U-Step's ultra stable foundation is key.
Read Press ReleaseThis broad method-of-use patent application covers the combined use of AMPAKINE compounds and metabotropic glutamate receptor type 5 (mGluR5) antagonists for the treatment of Fragile X syndrome.
Read Press ReleaseThe award will be used to test Cortex's selected proprietary High Impact AMPAKINE drug candidates in the mouse MPTP model of Parkinson's disease (PD), a well-validated model that exhibits many of the hallmarks of human Parkinson's disease and h
Read Press ReleaseToday almost everyone knows a family member or friend who is battling a life threatening disease. As our planet becomes more polluted our foods become more processed and our lives more stressful, it seems harder to stay healthy.
Read Press Release